CIRCULOGENE Appoints Stephen Unger Main Economic Officer

BIRMINGHAM, Ala.–(Business enterprise WIRE)–CIRCULOGENE, an ground breaking molecular diagnostics company transforming precision medicine by immediate delivery of actionable final results, announced currently that Stephen Unger has joined the company as Main Economic Officer. Mr. Unger has far more than 25 decades of financial working experience within existence sciences through senior roles in investment decision banking, public accounting and personal industry. He earlier served as Main Fiscal Officer of Quotient Minimal, which concluded a profitable original public supplying in 2014.

“We are delighted to welcome Stephen to our crew and are energized by his eagerness to assistance us generate accelerated development,” reported Mike Mullen, CIRCULOGENE President and CEO. “Steve’s wide money administration and capital marketplaces practical experience within just the diagnostics sector, combined with a track history of company finance execution, helps make this a best in shape.”

“I am thrilled to join the proficient workforce of CIRCULOGENE that is clearly earning a variance in the life of most cancers clients by means of the shipping and delivery of exceptionally exact and immediate diagnostic examination final results,” claimed Stephen Unger. “CIRCULOGENE’s proprietary approach for advanced up coming-technology sequencing is special inside of the liquid biopsy marketplace, necessitating just 1 4mL tube to comprehensive a comprehensive assortment of genomic testing, enabling faster turnaround instances for most cancers therapy variety, response monitoring, and condition recurrence evaluation.”

Mr. Unger most just lately served as a Running Director of Equity Research at Needham & Enterprise, LLC next the Existence Science Equipment and Diagnostics sector, the place he targeted on significant-expansion companies furnishing modern precision drugs options to combat most cancers. Mr. Unger is a Chartered Economical Analyst, a Licensed Community Accountant (inactive) and member of the New York Culture of Safety Analysts. He holds a Grasp of Company Administration diploma from the University of Chicago Booth College of Organization and a Bachelor of Small business Administration degree from the University of Wisconsin-Madison.

About CIRCULOGENE

Reworking precision drugs via swift shipping and delivery of actionable effects, CIRCULOGENE delivers thorough biomarker testing for a broad range of cancers, allowing doctors to match affected individual results with unique therapies (or clinical trials) in just a person week. The corporation has developed proprietary up coming-era sequencing (NGS) and qPCR techniques that deliver a complete genomic load evaluation, enabling greater knowledge accuracy to assistance clinicians choose targeted therapies, check efficacy and assess recurrence for most cancers individuals. Making use of proprietary liquid biopsy innovation for cfDNA and cfRNA—including PD-L1 and MSI detection— CIRCULOGENE can detect circulating germline and somatic mutations and RNA fusions all from a one 4mL tube of blood, tailoring qualified remedy and immunotherapy without having hold off.

CIRCULOGENE is a Medical Laboratory Improvement Amendments (CLIA) and Faculty of American Pathologists (CAP) qualified laboratory and a Verified Seller for the federal Procedure for Award Management. For a lot more data, visit our site, join with us on LinkedIn, Fb and Twitter, or e mail us at [email protected] or get in touch with 855-614-7083. Clinicians fascinated in purchasing assessments could visit the Call site on CIRCULOGENE’s site.